DFC_ARAMIS Registry

Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) registry patients who are on novel oral anticoagulants in community practice.

Inclusion Criteria:

•Age 18 years or older
•Have been diagnosed with acute ischemic stroke and have been treated with dabigatran, rivaroxaban, apixaban, edoxaban within 7 days prior to admission, or
•Have been diagnosed with intracerebral hemorrhage and have been treated with warfarin or one of the novel oral anticoagulants within 7 days prior to admission
•ARAMIS follow-up study: Ability of patient or legally authorized representative to provide informed consent for longitudinal follow-up indicating they understand the purpose and the requirements of the study and are willing to participate.

Exclusion Criteria:

•Patients who are transferred from another hospital (unless directly transferred from another hospital emergency department (ED) within 24 hours) or discharged to other acute care facility will be excluded.
N/A
NCT02478177
Neurosciences
Brain
Karen Bacosa
Duke Clinical Research Institute
Karen Bacosa
  • Providence Los Angeles Research Center
  • Providence St. Joseph Medical Center (PSJMC)